Regional Health Properties Reports Third Quarter 2024 Financial Results
Regional Health Properties Reports Third Quarter 2024 Financial Results
ATLANTA, GA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the "Company", "Regional", "we", "us" or "our") (NYSE American: RHE) (NYSE American: RHE-PA), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, today announced its financial results for the third quarter ended September 30, 2024.
亞特蘭大,喬治亞州,2024年11月26日(環球新聞稿)-- 地區健康物業公司("公司"、"地區"、"我們"、"我們"或"我們的")(紐交所美國:RHE)(紐交所美國:RHE-PA),是一家自我管理的醫療保健房地產投資公司,主要投資於用於老年生活和長期護理的房地產,今天公佈了截至2024年9月30日的第三季度財務業績。
THIRD QUARTER 2024 FINANCIAL
2024年第三季度財務
- Reduced loss from operations year over year from $0.4 million in the prior year quarter to $0.3 million in the current quarter
- Generated $1.0 million of Adjusted EBITDA1 in the quarter, compared to $0.6 million in the third quarter of 2023
- Collected 80.3% of contractual rent during Q3 2024. We are working with our tenants and have a positive outlook on collectability during Q4 2024
- 與去年同期相比,運營損失從40萬美元減少至30萬美元
- 本季度產生了100萬美元的調整後息稅折舊攤銷前利潤(EBITDA1),而2023年第三季度爲60萬美元
- 在2024年第三季度收取了80.3%的合同租金。我們正在與我們的租戶合作,並對2024年第四季度的收款能力持積極展望
THIRD QUARTER 2024 BUSINESS HIGHLIGHTS
2024年第三季度業務亮點
- The Healthcare Services segment produced its first positive EBITDA quarter since taking back operations of two facilities in 2022
- Our Meadowood facility in Glencoe, AL has achieved its highest occupancy since taking back the facility in 2022
- Regional's portfolio CMS star rating is the highest in over two years
- 醫療服務部門自2022年重新接管兩家設施以來,首次實現正的EBITDA季度。
- 我們位於阿拉巴馬州格倫科的梅多伍德設施自2022年重新接管以來,已實現最高入住率。
- 區域型的CMS科創板評級爲兩年來最高。
MANAGEMENT COMMENTS
管理層評論
Brent Morrison, Regional's President, Chief Executive Officer, and Chairman, commented, "The third quarter continues Regional's turnaround. While our rent collections in the quarter were less than ideal, we have taken additional steps to work with our operating partners and anticipate collecting back rent."
區域型總裁、首席執行官兼董事長布倫特·莫里森評論道:"第三季度繼續推動區域型的 turnaround。雖然我們本季度的租金回收情況不盡理想,但我們已採取額外措施與我們的運營合作伙伴合作,並預計將收回拖欠租金。"
Mr. Morrison continued, "Subsequent to quarter end, we entered into a management contract with CJM Advisors ("CJM") to manage our Sylva, NC facility. We are excited to work with Chris Murphy, former COO of Regency Integrated Health Systems and the entire CJM team to further the financial performance of our asset."
莫里森先生繼續說道:"在季度結束後,我們與CJm Advisors("CJM")簽訂了一份管理合同,以管理我們在北卡羅來納州Sylva的設施。我們很高興能與前Regency Integrated Health Systems首席運營官克里斯·墨菲及整個CJm團隊合作,進一步提升我們資產的財務表現。"
FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2024
2024年9月30日結束季度的財務業績
For the third quarter of 2024, the Company reported total revenue of $4.2 million, a net loss of $1.0 million, EBITDA2 of $0.2 million and Adjusted EBITDA of $1.0 million.
在2024年第三季度,公司報告總營收爲420萬,淨虧損爲100萬,EBITDA爲20萬,調整後EBITDA爲100萬。
BALANCE SHEET AND LIQUIDITY
資產負債表及流動性
As of September 30, 2024, the Company had $49.7 million, net of outstanding indebtedness with a weighted-average annual interest rate of 5.1% and a weighted-average maturity of approximately 17 years. For the nine months ended September 30, 2024, net cash provided by operating activities was $1.0 million. The Company is currently negotiating various methods to collect the remaining unpaid rent and notes receivable.
截至2024年9月30日,公司擁有淨資產4970萬美元,扣除未償還債務,年加權平均利率爲5.1%,加權平均到期時間約爲17年。截至2024年9月30日的九個月中,營運活動提供的淨現金爲100萬美元。公司目前正在商討多種方法以收回尚未支付的租金和應收票據。
Subsequent to quarter end, we obtained a $0.5 million line of credit and expect to be current on all debt payments and back in compliance with all loan documents during Q4 2024.
在季度結束後,我們獲得了一條50萬美元的信用額度,並預計在2024年第四季度將能按時支付所有債務並恢復遵循所有貸款文件的合規性。
About Regional Health Properties
關於地區衛生物業
Regional Health Properties, Inc., a Georgia corporation, is a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care. For more information, visit .
區域健康物業公司是一家喬治亞州的自我管理醫療保健房地產投資公司,主要投資於用於老年生活和長期護理的房地產。欲了解更多信息,請訪問 .
Important Cautions Regarding Forward-Looking Statements
關於前瞻性聲明的重要注意事項
This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as "expects," "intends," "believes," "anticipates," "plans," "likely," "will," "seeks," "estimates" and variations of such words and similar expressions are intended to identify such forward-looking statements. This press release includes forward-looking statements that reflect the Company's current views with respect to, among other things, its business, operations, financial performance, revenue, capital structure, the impact of the exchange offer and economic developments.
本新聞稿包含根據《1933年證券法》第27A條及《1934年證券交易法》第21E條的定義的前瞻性聲明。諸如「預計」、「打算」、「相信」、「預期」、「計劃」、「可能」、「將」、「尋求」、「估計」及此類詞彙及類似表達的變體旨在識別此類前瞻性聲明。本新聞稿包含反映公司當前觀點的前瞻性聲明,涉及其業務、運營、財務表現、營業收入、資本結構、交易所收購的影響及經濟發展等多個方面。
Forward-looking statements, by their nature, involve estimates, projections, goals, forecasts and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected or contemplated by our forward-looking statements due to various factors, including, among others: our dependence on the operating success of our operators; the amount of, and our ability to service, our indebtedness; covenants in our debt agreements that may restrict our ability to make investments, incur additional indebtedness and refinance indebtedness on favorable terms; the availability and cost of capital; our ability to raise capital through equity and debt financings or through the sale of assets; increases in market interest rates and inflation; our ability to meet the continued listing requirements of the NYSE American LLC and to maintain the listing of our securities thereon; the effect of increasing healthcare regulation and enforcement on our operators and the dependence of our operators on reimbursement from governmental and other third-party payors; the relatively illiquid nature of real estate investments; the impact of litigation and rising insurance costs on the business of our operators; the impact on us of litigation relating to our prior operation of our healthcare properties; the effect of our operators declaring bankruptcy, becoming insolvent or failing to pay rent as due; the ability of any of our operators in bankruptcy to reject unexpired lease obligations and to impede our ability to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations; our ability to find replacement operators and the impact of unforeseen costs in acquiring new properties; epidemics or pandemics, including the COVID-19 pandemic, and the related impact on our tenants, operators and healthcare facilities; and other factors discussed from time to time in our news releases, public statements and documents filed by us with the Securities and Exchange Commission from time to time, including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. These forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this press release, and we expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, to reflect any change in our expectations with regard thereto or any other change in events, conditions or circumstances on which any such statement is based, except to the extent otherwise required by applicable law.
前瞻性聲明本質上涉及估算、預測、目標、預期和假設,並受到風險和不確定性的影響,這可能導致實際結果與我們前瞻性聲明中預測或預期的結果存在重大差異,這些差異可能由多種因素造成,包括但不限於:我們對經營者運營成功的依賴;我們的債務金額及我們清償債務的能力;可能限制我們投資、承擔額外債務和以有利條款重新融資的債務協議中的契約;資本的可用性和成本;我們通過股權和債務融資或資產出售籌集資金的能力;市場利率和通貨膨脹的上升;我們滿足紐約證券交易所上市持續要求的能力以及保持證券在其上的上市;醫療保健監管和執法日益嚴格對我們的經營者的影響,以及我們的經營者對政府和其他第三方支付者的報銷的依賴;房地產投資的相對流動性差;訴訟和保險成本上升對我們經營者業務的影響;與我們之前運營醫療保健物業相關的訴訟對我們的影響;我們的經營者申請破產、資不抵債或未按時支付租金的影響;任何破產經營者拒絕未到期租賃義務的能力,這可能妨礙我們在破產程序期間收取未支付的租金或利息並保留債務人義務的按金;我們找到替代經營者的能力及收購新物業所涉及的不可預見成本的影響;流行病或大流行,例如COVID-19大流行,以及對我們的租戶、經營者和醫療設施的相關影響;以及我們不時在新聞稿、公開聲明及提交給證券交易委員會的文件中討論的其他因素,包括我們的年度報告(Form 10-K)、季度報告(Form 10-Q)和當前報告(Form 8-K)。這些前瞻性聲明及此類風險、不確定性和其他因素僅在本新聞稿發佈之日有效,我們明確不承擔任何更新或修訂此聲明的義務,以反映我們對此的預期變化或任何此類聲明所依據的事件、條件或情況的其他變動,除非適用法律另有要求。
Company Contact |
Brent Morrison, CFA |
Chief Executive Officer & President |
Regional Health Properties, Inc. |
Tel (678) 368-4402 |
Brent.morrison@regionalhealthproperties.com |
公司聯繫 Marcia Novero Innodata Inc. Mnovero@innodata.com (201) 371-8015 |
Brent Morrison,特許金融分析師 |
PEAKSTONE房地產投資信託 |
regional health properties公司 |
電話 (678) 368-4402 |
Brent.morrison@regionalhealthproperties.com |
REGIONAL HEALTH PROPERTIES, INC. | ||||||||||||||||
STATEMENT OF OPERATIONS | ||||||||||||||||
(in thousands, except for per share and shares outstanding information) | ||||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
Revenues: | ||||||||||||||||
Patient care revenues | $ | 2,585 | $ | 2,136 | $ | 7,418 | $ | 6,577 | ||||||||
Rental revenues | 1,640 | 1,739 | 5,257 | 5,170 | ||||||||||||
Management fees | — | 263 | — | 788 | ||||||||||||
Other revenues | — | — | — | 107 | ||||||||||||
Total revenues | 4,225 | 4,138 | 12,675 | 12,642 | ||||||||||||
Expenses: | ||||||||||||||||
Patient care expense | 2,179 | 2,153 | 6,462 | 6,444 | ||||||||||||
Facility rent expense | 149 | 149 | 446 | 446 | ||||||||||||
Cost of management fees | — | 156 | — | 442 | ||||||||||||
Depreciation and amortization | 474 | 526 | 1,499 | 1,738 | ||||||||||||
General and administrative expense | 1,224 | 1,329 | 4,085 | 4,284 | ||||||||||||
Credit loss expense | 499 | 229 | 563 | 269 | ||||||||||||
Total expenses | 4,525 | 4,542 | 13,055 | 13,623 | ||||||||||||
Income (loss) from operations | (300) | (404) | (380) | (981) | ||||||||||||
Other expense: | ||||||||||||||||
Interest expense, net | 677 | 708 | 2,021 | 2,066 | ||||||||||||
Other expense, net | 5 | (139) | 249 | 603 | ||||||||||||
Total other expense, net | 682 | 569 | 2,270 | 2,669 | ||||||||||||
Net loss | $ | (982) | $ | (973) | $ | (2,650) | $ | (3,650) | ||||||||
Preferred stock dividends-gain on extinguishment | — | 43,395 | — | 43,395 | ||||||||||||
Net income (loss) attributable to Regional Health Properties, Inc. common stockholders | $ | (982) | $ | 42,422 | $ | (2,650) | $ | 39,745 | ||||||||
Net income (loss) per share of common stock attributable to Regional Health Properties, Inc. | ||||||||||||||||
Basic: | $ | (0.52) | $ | (0.52) | $ | (1.42) | $ | 21.18 | ||||||||
Diluted: | $ | (0.52) | $ | (0.52) | $ | (1.42) | $ | 21.18 | ||||||||
Weighted average shares of common stock outstanding: | ||||||||||||||||
Basic: | 1,904,028 | 1,883,028 | 1,863,314 | 1,876,138 | ||||||||||||
Diluted: | 1,904,028 | 1,883,028 | 1,863,314 | 1,876,138 |
區域衛生物業公司,股份有限公司。 | ||||||||||||||||
營業報表 | ||||||||||||||||
(以千爲單位,除每股及已發行股份外的信息) | ||||||||||||||||
截至三個月 9月30日, |
截至九個月 9月30日, |
|||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
營業收入: | ||||||||||||||||
患者護理收入 | $ | (1,447) | $ | 2,136 | $ | 7,418 | $ | 6,577 | ||||||||
租賃收入 | 1,640 | 1,739 | 5,257 | 5,170 | ||||||||||||
管理費用 | — | 263 | — | 788 | ||||||||||||
其他營業收入 | — | — | — | 107 | ||||||||||||
總收入 | 4,225 | 4,138 | 12,675 | 12,642 | ||||||||||||
費用: | ||||||||||||||||
患者護理費用 | 2,179 | 2,153 | 6,462 | 6,444 | ||||||||||||
設施租賃費用 | 149 | 149 | 446 | 446 | ||||||||||||
管理費用成本 | — | 156 | — | 442 | ||||||||||||
折舊和攤銷 | 474 | 526 | 1,499 | 1,738 | ||||||||||||
一般和行政費用 | 1,224 | 1,329 | 4,085 | 4,284 | ||||||||||||
信用損失費用 | 499 | 229 | 563 | 269 | ||||||||||||
總支出 | 4,525 | 4,542 | 13,055 | 13,623 | ||||||||||||
營業收入(虧損) | (300) | (404) | (380) | (981) | ||||||||||||
其他支出: | ||||||||||||||||
利息費用,淨額 | 677 | 708 | 2,021 | 2,066 | ||||||||||||
其他費用,淨額 | 5 | (139) | 249 | 603 | ||||||||||||
其他費用總計,淨額 | 682 | 569 | 2,270 | 2,669 | ||||||||||||
淨虧損 | $ | (982) | $ | (-973) | $ | (2,650) | $ | (3,650) | ||||||||
優先股送轉-熔斷收益 | — | 43,395 | — | 43,395 | ||||||||||||
歸屬於區域型健康物業公司普通股股東的淨利潤(虧損) | $ | (982) | $ | 42,422 | $ | (2,650) | $ | 39,745 | ||||||||
歸屬於區域健康物業公司的每股普通股淨利潤(虧損) | ||||||||||||||||
基本的: | $ | (0.52) | $ | (0.52) | $ | (1.42) | $ | 21.18 | ||||||||
稀釋的: | $ | (0.52) | $ | (0.52) | $ | (1.42) | $ | 21.18 | ||||||||
普通股流通加權平均股數: | ||||||||||||||||
基本的: | 1,904,028 | 1,883,028 | 1,863,314 | 1,876,138 | ||||||||||||
稀釋的: | 1,904,028 | 1,883,028 | 1,863,314 | 1,876,138 |
REGIONAL HEALTH PROPERTIES, INC. | ||||||||
BALANCE SHEET | ||||||||
(in thousands) | ||||||||
September 30, 2024 | December 31, 2023 | |||||||
(Unaudited) | ||||||||
ASSETS | ||||||||
Property and equipment, net | $ | 39,429 | $ | 40,398 | ||||
Asset held for sale, net | 4,851 | 4,939 | ||||||
Cash | 497 | 953 | ||||||
Restricted cash | 3,005 | 3,231 | ||||||
Accounts receivable, net of allowances of $2,082 and $2,040 | 2,034 | 1,403 | ||||||
Prepaid expenses and other | 663 | 613 | ||||||
Notes receivable | 594 | 1,044 | ||||||
Intangible assets - bed licenses | 2,471 | 2,471 | ||||||
Intangible assets - lease rights, net | 74 | 87 | ||||||
Right-of-use operating lease assets | 2,263 | 2,556 | ||||||
Goodwill | 1,585 | 1,585 | ||||||
Straight-line rent receivable | 2,594 | 2,901 | ||||||
Total assets | $ | 60,060 | $ | 62,181 | ||||
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY | ||||||||
Senior debt, net | $ | 39,509 | $ | 40,401 | ||||
Debt related to asset held for sale, net | 3,354 | 3,454 | ||||||
Bonds, net | 5,849 | 5,991 | ||||||
Other debt, net | 945 | 889 | ||||||
Accounts payable | 3,707 | 2,493 | ||||||
Accrued expenses | 4,703 | 4,060 | ||||||
Operating lease obligation | 2,592 | 2,917 | ||||||
Other liabilities | 1,781 | 1,791 | ||||||
Total liabilities | 62,440 | 61,996 | ||||||
Stockholders' equity (deficit): | ||||||||
Common stock and additional paid-in capital | 63,144 | 63,059 | ||||||
Preferred stock, Series A | 426 | 426 | ||||||
Preferred stock, Series B | 18,602 | 18,602 | ||||||
Accumulated deficit | (84,552) | (81,902) | ||||||
Total stockholders' (deficit) equity | (2,380) | 185 | ||||||
Total liabilities and stockholders' equity (deficit) | $ | 60,060 | $ | 62,181 |
區域衛生物業公司,股份有限公司。 | ||||||||
資產負債表 | ||||||||
(以千爲單位) | ||||||||
2024年9月30日 | 2023年12月31日 | |||||||
(未經審計) | ||||||||
資產 | ||||||||
物業和設備,淨值 | $ | 39,429 | $ | 40,398 | ||||
待售資產,淨值 | 4,851 | 4,939 | ||||||
現金 | 497 | 953 | ||||||
受限現金 | 3,005 | 3,231 | ||||||
應收賬款,扣除$2,082和$2,040的準備金 | 2,034 | 1,403 | ||||||
預付費用及其他 | 663 | 613 | ||||||
應收票據 | 594 | 1,044 | ||||||
無形資產 - 牀位許可證 | 2,471 | 2,471 | ||||||
無形資產 - 租賃權,淨額 | 74 | 87 | ||||||
使用權運營租賃資產 | 2,263 | 2,556 | ||||||
商譽 | 1,585 | 1,585 | ||||||
直線租金應收賬款 | 2,594 | 2,901 | ||||||
總資產 | $ | 60,060 | $ | 62,181 | ||||
負債和股東(赤字)權益 | ||||||||
優先債務,淨額 | $ | 39,509 | $ | 40,401 | ||||
與待售資產相關的債務,淨額 | 3,354 | 3,454 | ||||||
債券,淨額 | 5,849 | 5,991 | ||||||
其他債務,淨額 | 945 | 889 | ||||||
應付賬款 | 3,707 | 2,493 | ||||||
應計費用 | 4,703 | 4,060 | ||||||
租賃運營義務 | 2,592 | 2,917 | ||||||
其他負債 | 1,781 | 1,791 | ||||||
總負債 | 62,440 | 61,996 | ||||||
股東權益(虧損): | ||||||||
普通股票和額外支付的資本 | 63,144 | 63,059 | ||||||
A公司優先股 | 426 | 426 | ||||||
優先股,B系列 | 18,602 | 18,602 | ||||||
累積赤字 | (84,552) | (81,902) | ||||||
股東(赤字)權益合計 | (2,380) | 185 | ||||||
負債和股東權益合計(赤字) | $ | 60,060 | $ | 62,181 |
REGIONAL HEALTH PROPERTIES, INC. | ||||||||||||||||||||||||||||
DEBT SUMMARY | ||||||||||||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||||||
September 30, 2024 | ||||||||||||||||||||||||||||
Maturity | Interest Rate | Principal | % of Principal | Deferred financing costs | Unamortized discount on bonds | Net Carrying Value | ||||||||||||||||||||||
Total Fixed Rate Debt | 1/16/2042 | 4.29% | 43,092 | 85.0% | (715) | (110) | 42,267 | |||||||||||||||||||||
Total Floating Rate Debt | 10/3/2036 | 9.67% | 7,578 | 15.0% | (188) | - | 7,390 | |||||||||||||||||||||
Total | $ | 50,670 | 100.0% | $ | (903) | $ | (110) | $ | 49,657 |
區域衛生物業公司,股份有限公司。 | ||||||||||||||||||||||||||||
債務總結 | ||||||||||||||||||||||||||||
(以千爲單位) | ||||||||||||||||||||||||||||
2024年9月30日 | ||||||||||||||||||||||||||||
到期 | 利率 | 負責人 | % 的本金 | 遞延融資費用 | 未攤銷的債券折扣 | 淨賬面價值 | ||||||||||||||||||||||
總固定利率債務 | 1/16/2042 | 4.29% | 43,092 | 85.0% | (715) | (110) | 42,267 | |||||||||||||||||||||
總浮動利率債務 | 10/3/2036 | 9.67% | 7,578 | 15.0% | (188) | - | 7,390 | |||||||||||||||||||||
總計 | $ | 50,670 | 100.0% | $ | (903) | $ | (110) | $ | 49,657 |
Calculation of Non-GAAP Financial Measures
非GAAP財務指標的計算
This press release presents information about EBITDA and adjusted EBITDA, which are non-GAAP financial measures provided as a supplement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Company believes that these non-GAAP financial measures provide meaningful supplemental information regarding its performance by excluding certain items that may not be indicative of its recurring core business operating results. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning and forecasting future periods. These non-GAAP financial measures also facilitate management's internal comparisons to the Company's historical performance. The Company believes these non-GAAP financial measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making.
This press release presents information about EBITDA and adjusted EBITDA, which are non-GAAP financial measures provided as a supplement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). The Company believes that these non-GAAP financial measures provide meaningful supplemental information regarding its performance by excluding certain items that may not be indicative of its recurring core business operating results. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance and when planning and forecasting future periods. These non-GAAP financial measures also facilitate management's internal comparisons to the Company's historical performance. The Company believes these non-GAAP financial measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making.
These non-GAAP financial measures are presented for supplemental informational purposes only. These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or as a substitute for, GAAP financial measures. These non-GAAP financial measures may differ from the non-GAAP financial measures used by other companies. A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measure is provided below for each of the fiscal periods indicated.
These non-GAAP financial measures are presented for supplemental informational purposes only. These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation from, or as a substitute for, GAAP financial measures. These non-GAAP financial measures may differ from the non-GAAP financial measures used by other companies. A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measure is provided below for each of the fiscal periods indicated.
A reconciliation of EBITDA and adjusted EBITDA is as follows:
A reconciliation of EBITDA and adjusted EBITDA is as follows:
REGIONAL HEALTH PROPERTIES, INC. | ||||||||||||||||
RECONCILIATION OF NET LOSS TO NON-GAAP FINANCIAL MEASURES | ||||||||||||||||
(in thousands) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
Net loss | $ | (982) | $ | (973) | $ | (2,650) | $ | (3,650) | ||||||||
Depreciation and amortization | 474 | 526 | 1,499 | 1,738 | ||||||||||||
Interest expense, net | 677 | 708 | 2,021 | 2,066 | ||||||||||||
Amortization of employee stock compensation | 19 | 85 | 85 | 321 | ||||||||||||
EBITDA | 188 | 346 | 955 | 475 | ||||||||||||
Credit loss expense | 499 | 229 | 563 | 269 | ||||||||||||
Other expense (income), net | 5 | (139) | 249 | 603 | ||||||||||||
Gain (loss) from write-off of liabilities and other credit balances from discontinued operations | 3 | (200) | 180 | (231) | ||||||||||||
Expenses related to preferred stock recapitalization | - | 95 | - | 768 | ||||||||||||
Other one-time costs | 179 | 6 | 319 | 270 | ||||||||||||
Project costs | 20 | 70 | 85 | 237 | ||||||||||||
Tail insurance on legacy facilities | 55 | 127 | 262 | 382 | ||||||||||||
One-time income adjustment - quality incentive program (1) | 49 | 49 | (49) | (354) | ||||||||||||
Adjusted EBITDA from operations | $ | 998 | $ | 583 | $ | 2,564 | $ | 2,419 | ||||||||
(1) Amounts represent adjustments for annual payments received and related amortization of payments for each respective period. |
區域衛生物業公司,股份有限公司。 | ||||||||||||||||
淨虧損與非GAAP財務指標的調節 | ||||||||||||||||
(以千爲單位) | ||||||||||||||||
(未經審計) | ||||||||||||||||
截至三個月 9月30日, |
截至九個月 9月30日, |
|||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
淨虧損 | $ | (982) | $ | (-973) | $ | (2,650) | $ | (3,650) | ||||||||
折舊和攤銷 | 474 | 526 | 1,499 | 1,738 | ||||||||||||
利息費用,淨額 | 677 | 708 | 2,021 | 2,066 | ||||||||||||
員工股票補償的攤銷 | 19 | 85 | 85 | 321 | ||||||||||||
EBITDA | 188 | 346 | 955 | 475 | ||||||||||||
信用損失費用 | 499 | 229 | 563 | 269 | ||||||||||||
其他費用(收益),淨額 | 5 | (139) | 249 | 603 | ||||||||||||
因註銷不再繼續經營的負債和其他信用餘額而產生的收益(損失) | 3 | (200) | 180 | (231) | ||||||||||||
與優先股資本重組相關的費用 | - | 95 | - | 768 | ||||||||||||
其他一次性費用 | 179 | 6 | 319 | 270 | ||||||||||||
項目成本 | 20 | 70 | 85 | 237 | ||||||||||||
遺留設施的尾部保險 | 55 | 127 | 262 | 382 | ||||||||||||
一次性收入調整 - 質量激勵計劃 (1) | 49 | 49 | (49) | (354) | ||||||||||||
來自控件的調整後 EBITDA | $ | 998 | $ | 583 | $ | 2,564 | $ | 2,419 | ||||||||
(1) 金額代表每個相關期間收到的年度付款的調整及相關的付款攤銷。 |
1 Adjusted EBITDA is a non-GAAP financial measure. See "Calculation of Non-GAAP Financial Measures" for important additional information.
2 EBITDA is a non-GAAP financial measure. See "Calculation of Non-GAAP Financial Measures" for important additional information.
1 調整後的EBITDA是非公認會計原則(GAAP)財務指標。有關重要附加信息,請參見「非GAAP財務指標的計算」。
2 EBITDA是非公認會計原則(GAAP)財務指標。有關重要附加信息,請參見「非GAAP財務指標的計算」。
譯文內容由第三人軟體翻譯。